LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation
Provided By GlobeNewswire
Last update: Apr 16, 2025
Exemption from the $5.1 million repayment obligation strengthens LAVA’s balance sheet
Underscores focus on cost curtailment and strategic option evaluation
Read more at globenewswire.comNASDAQ:LVTX (11/20/2025, 8:00:00 PM)
1.74
-0.07 (-3.87%)
Find more stocks in the Stock Screener
